Catalent Inc (NASDAQ:CTLT) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Thursday.

A number of other equities research analysts have also recently commented on the company. Bank of America Corporation reiterated a “buy” rating and set a $38.00 target price (up from $37.00) on shares of Catalent in a research note on Friday, July 21st. Zacks Investment Research cut Catalent from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. BidaskClub cut Catalent from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. William Blair reiterated an “ourperform” rating on shares of Catalent in a research note on Tuesday, August 29th. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $45.00 target price on shares of Catalent in a research note on Tuesday, August 29th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $36.22.

Catalent (NASDAQ:CTLT) traded down 2.42% during trading on Thursday, hitting $40.35. 1,306,462 shares of the company’s stock traded hands. Catalent has a 52-week low of $21.83 and a 52-week high of $42.22. The company has a market cap of $5.05 billion and a PE ratio of 46.38. The company’s 50 day moving average price is $36.24 and its 200 day moving average price is $33.10.

Catalent (NASDAQ:CTLT) last released its earnings results on Monday, August 28th. The company reported $0.65 EPS for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.08. The company had revenue of $616.90 million for the quarter, compared to analysts’ expectations of $547.48 million. Catalent had a return on equity of 16.95% and a net margin of 4.88%. The business’s revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.52 EPS. Analysts expect that Catalent will post $1.60 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Catalent Inc (CTLT) Upgraded at ValuEngine” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/09/09/catalent-inc-ctlt-upgraded-at-valuengine.html.

In related news, SVP Christine Dolan sold 745 shares of Catalent stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $34.85, for a total value of $25,963.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

A number of institutional investors and hedge funds have recently made changes to their positions in CTLT. Capstone Asset Management Co. increased its holdings in Catalent by 3.4% in the 1st quarter. Capstone Asset Management Co. now owns 9,900 shares of the company’s stock worth $280,000 after acquiring an additional 330 shares during the last quarter. Nationwide Fund Advisors increased its holdings in Catalent by 8.0% in the 1st quarter. Nationwide Fund Advisors now owns 291,103 shares of the company’s stock worth $8,244,000 after acquiring an additional 21,540 shares during the last quarter. Acadian Asset Management LLC increased its holdings in Catalent by 115.7% in the 1st quarter. Acadian Asset Management LLC now owns 5,847 shares of the company’s stock worth $166,000 after acquiring an additional 3,136 shares during the last quarter. Glen Harbor Capital Management LLC increased its holdings in Catalent by 17.7% in the 1st quarter. Glen Harbor Capital Management LLC now owns 6,328 shares of the company’s stock worth $179,000 after acquiring an additional 952 shares during the last quarter. Finally, Strs Ohio increased its holdings in Catalent by 16.5% in the 1st quarter. Strs Ohio now owns 9,900 shares of the company’s stock worth $280,000 after acquiring an additional 1,400 shares during the last quarter.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.